Richard H. Bell

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Martine Piccart, Marion Procter, Brian Leyland‐Jones et al. · New England Journal of Medicine · 2005 · 5.1K citations · Full text

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

Ian Smith, Marion Procter, Richard D. Gelber et al. · The Lancet · 2007 · 1.5K citations

Breast Oncology, Medicine, Adjuvant Chemotherapy +6

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

James R. Berenson, Alan Lichtenstein, Lester Porter et al. · New England Journal of Medicine · 1996 · 1.1K citations

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

David Cameron, Martine Piccart, Richard D. Gelber et al. · The Lancet · 2017 · 1K citations · Full text

Herceptin Adjuvant, Breast Oncology, Oncology +7

13-<i>cis</i>-Retinoic Acid in the Treatment of Oral Leukoplakia

Waun Ki Hong, J Endicott, Loretta M. Itri et al. · New England Journal of Medicine · 1986 · 826 citations

Ocular Disease, Oncology, Chemoprevention Strategy +13